Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by capebretongirlon Feb 15, 2021 1:23pm
229 Views
Post# 32568717

RE:RE:US$40 million Agreement

RE:RE:US$40 million Agreement
TrippingAgain2 wrote: Oncore lol. I've been asking that question for almost a year now. Absolutely no transparency within management. They are so aweful they can even update long investors on the largest deal they have every been a part of. Its almost impossible lol. Tripp was happy to tell everyone how undervalued and important this deal was up until the deal started to kick in. 

Best play here is to jump on and buy early or mid-March and wait for the Q1 Aristotle NR Tripp has locked himself into. Then swing it 1-2 days after Aristotle NR which I agree will provide a large POP in the SP in this market environement. There is a risk it is delayed seeing as I cant recall any serious timeframe SZLS has ever hit without delays or setbacks just being honest. They really need someone new at the top of this company asap if they want to ever fly.



So now your strategy is to convince holders they should sell the day or day after the NR release so as to curb the upward swing of the sp - just get everyone to bail out so the sp drops - right?  Your intentions are quite transparent here as you are not a friend of this stock......... 

<< Previous
Bullboard Posts
Next >>